| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 9 |
| 1 | ADALIMUMAB-AATY | 5 |
| 2 | CLINDAMYCIN | 3 |
| 3 | CLINDAMYCIN PHOSPHATE | 3 |
| 4 | RIFAMPIN | 3 |
| 5 | RISANKIZUMAB-RZAA | 3 |
| 6 | TAZAROTENE | 3 |
| 7 | CEPHALEXIN | 2 |
| 8 | DOXYCYCLINE | 2 |
| 9 | DOXYCYCLINE HYCLATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFAROTENE | 1 | 0.0055 |
| 1 | TAZAROTENE | 3 | 0.0025 |
| 2 | CLINDAMYCIN PHOSPHATE | 3 | 0.0005 |
| 3 | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0.0002 |
| 5 | RIFAMPIN | 3 | 0.0002 |
| 6 | SOTALOL HYDROCHLORIDE | 2 | 0.0001 |
| 7 | LINAGLIPTIN | 2 | 0.0001 |
| 8 | ADALIMUMAB-AATY | 5 | 0.0001 |
| 9 | SENNOSIDES 8.6 MG TABLETS | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 3 |
| 1 | Rifamycin Antibacterial [EPC] | 3 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 |
| 4 | Tetracycline-class Drug [EPC] | 2 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 6 | Aluminum Complex [EPC] | 1 |
| 7 | Azole Antifungal [EPC] | 1 |
| 8 | Calcium [EPC] | 1 |
| 9 | Catecholamine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antibacterial [EPC] | 3 | 0.0001 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 2 | 0.0001 |
| 2 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 3 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 4 | Tetracycline-class Drug [EPC] | 2 | 0.0000 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Catecholamine [EPC] | 1 | 0.0000 |
| 7 | Retinoid [EPC] | 3 | 0.0000 |
| 8 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Calcium [EPC] | 1 | 0.0000 |